Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

OBJECTIVE: We previously showed that exenatide (EXE) enhanced insulin secretion after 1 year of treatment, relative to insulin glargine (GLAR), with a similar glucose-lowering action. These effects were not sustained after a 4-week off-drug period. This article reports the results after additional 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunck, Mathijs C., Cornér, Anja, Eliasson, Bjorn, Heine, Robert J., Shaginian, Rimma M., Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161303/
https://www.ncbi.nlm.nih.gov/pubmed/21868779
http://dx.doi.org/10.2337/dc11-0291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161303/
https://www.ncbi.nlm.nih.gov/pubmed/21868779
http://dx.doi.org/10.2337/dc11-0291

Ejemplares similares